Related Experiment Video

Updated: May 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Mechanisms of anemia in CKD

Jodie L Babitt1, Herbert Y Lin

  • 1Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA. babitt.jodie@mgh.harvard.edu

Journal of the American Society of Nephrology : JASN
|September 1, 2012
PubMed

Insights

Anemia in chronic kidney disease (CKD) management is debated due to risks with erythropoiesis-stimulating agents. New research explores molecular causes of CKD anemia, paving the way for targeted diagnostics and treatments.

Area of Science:

  • Nephrology
  • Hematology
  • Molecular Medicine

Background:

  • Anemia is a frequent complication of chronic kidney disease (CKD), linked to adverse patient outcomes.
  • Current therapeutic strategies for anemia in CKD are controversial.
  • Erythropoiesis-stimulating agents (ESAs) have been associated with increased morbidity and mortality in recent clinical trials.

Purpose of the Study:

  • To review recent advancements in understanding the molecular mechanisms of anemia in CKD.
  • To highlight the potential for novel diagnostic and therapeutic approaches targeting the underlying pathophysiology of CKD-related anemia.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of molecular pathways implicated in the anemia of CKD.
  • Examination of emerging diagnostic and therapeutic strategies.

Main Results:

  • Recent research has elucidated key molecular mechanisms contributing to anemia in CKD patients.
  • Understanding these mechanisms offers a foundation for developing more precise interventions.
  • The focus is shifting from broad stimulation to targeted molecular approaches.

Conclusions:

  • New insights into the molecular basis of CKD anemia are emerging.
  • These discoveries promise to improve diagnostic accuracy and therapeutic efficacy.
  • Future treatments may directly address the specific molecular defects causing anemia in CKD.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...